This report translates the Bank's corporate commitment into increased efforts to control malaria. It lays the basis for a Booster Program for Malaria Control, through which the Bank will make an important contribution to malaria control in the years ahead. This effort will be undertaken in...

Although there have been studies of the cost-effectiveness of particular malaria interventions, there has been less analysis of broader aspects of value for money in malaria programming. In this paper, Paul Wilson and Ya'ir Aizenman examine opportunities for value for money in malaria control,...

It is often argued that engaging in indoor residual spraying (IRS) in areas with high coverage of mosquito bed nets may discourage net ownership and use. This is just a case of a public program inducing perverse incentives. We analyze new data from a randomized control trial conducted in Eritrea...

Phase 1 of the Affordable Medicines Facility for malaria (AMFm) is a $225 million initiative that was launched in 2010 in an effort to increase access to safe and effective artemisinin-based combination therapies (ACTs) by dramatically lowering their price with a global subsidy. The AMFm also...